1. Górska, Agata, Mazur, Antonina Joanna. 2022. Integrin-linked kinase (ILK): the known vs. the unknown and perspectives. In Cellular and molecular life sciences : CMLS, 79, 100. doi:10.1007/s00018-021-04104-1. https://pubmed.ncbi.nlm.nih.gov/35089438/
2. Martucci, Nicole, Michalopoulos, George K, Mars, Wendy M. 2021. Integrin Linked Kinase (ILK) and its Role in Liver Pathobiology. In Gene expression, 20, 201-207. doi:10.3727/105221621X16113475275710. https://pubmed.ncbi.nlm.nih.gov/33482930/
3. Liu, Rongrong, Shang, Wenjing, Liu, Yingying, Song, Xicheng, Han, Fengchan. 2024. Inhibition of the ILK-AKT pathway by upregulation of PARVB contributes to the cochlear cell death in Fascin2 gene knockout mice. In Cell death discovery, 10, 89. doi:10.1038/s41420-024-01851-5. https://pubmed.ncbi.nlm.nih.gov/38374196/
4. Eke, Iris, Hehlgans, Stephanie, Cordes, Nils. . There's something about ILK. In International journal of radiation biology, 85, 929-36. doi:10.3109/09553000903232892. https://pubmed.ncbi.nlm.nih.gov/19895269/
5. Dai, Jing, Matsui, Takashi, Abel, E Dale, Seidman, J G, Rosenzweig, Anthony. 2013. Deep sequence analysis of gene expression identifies osteopontin as a downstream effector of integrin-linked kinase (ILK) in cardiac-specific ILK knockout mice. In Circulation. Heart failure, 7, 184-93. doi:10.1161/CIRCHEARTFAILURE.113.000649. https://pubmed.ncbi.nlm.nih.gov/24319095/
6. Reyes-González, Jeyshka M, Quiñones-Díaz, Blanca I, Santana, Yasmarie, Fernández-de Thomas, Ricardo J, Vivas-Mejía, Pablo E. 2020. Downstream Effectors of ILK in Cisplatin-Resistant Ovarian Cancer. In Cancers, 12, . doi:10.3390/cancers12040880. https://pubmed.ncbi.nlm.nih.gov/32260415/